Background. Few cohort studies have adequate numbers of carefully reviewed deaths to allow an analysis of unique and shared risk factors for cause-specifi c mortality. Shared risk factors could be targeted for prevention of premature death and the study of longevity.
O LDER adults are heterogeneous in the prevalence and patterns of chronic disease and related disability ( 1 ) . We have previously shown that multiple aspects of chronic disease and lifestyle jointly and independently contributed to mortality risk in older adults ( 2 ) . Together, a number of these factors explained a large part of the association of older age with mortality but did not explain the excess mortality in men relative to women. It is not known whether these associations would differ for specifi c causes of death and whether risk factors would be similar or different across causes. The extent to which risk factors might be shared could indicate common pathways to longevity and a potential for greater longevity through reduction of shared risk factors.
Most previous epidemiological studies have assessed risk factors for either total mortality or a specifi c cause of death, such as cardiovascular disease or a specifi c cancer.
A literature review documents several risk factors that appear to be similar across diseases for some of the major causes of death. As examples, cigarette smoking is a risk factor for cardiovascular disease ( 3 ), stroke ( 4 ), chronic lung disease ( 5 ) , and lung and other cancers ( 6 ) , whereas obesity and glucose intolerance are risk factors for cardiovascular disease and stroke ( 7 ) and colon and other cancers ( 8 , 9 ) . Education level and other markers of socioeconomic status are also risk factors that are common to several major causes of death ( 10 ) . Infl ammatory markers, such as C-reactive protein (CRP) and interleukin-6 (IL-6) ( 11 ) , and the genetic marker, the apolipoprotein E ε 4 (ApoE ε 4) allele ( 12 , 13 ) , appear to be nonspecifi c markers that may refl ect an accelerated aging process and their absence may contribute to longevity. These associations for specifi c causes of death may or may not hold within a single cohort.
Total and Cause-Specifi c Mortality in the Cardiovascular
Health Study
In this report, we examined mortality rates in the Cardiovascular Health Study (CHS) cohort after 16 years of follow-up and reevaluated risk factors for total and causespecifi c mortality. We sought to determine the common and unique risk factors for several categories of specifi c causes of death.
M ethods

Study Population
The CHS is an ongoing, prospective observational study designed to determine the risk factors, consequences, and natural history of cardiovascular disease in men and women aged 65 years and older. A total of 5,888 men and women were enrolled in 1989 -1990 ( n = 5,201) and 1992 -1993 ( n = 687) from four U.S. communities: Sacramento County, California, Forsyth County, North Carolina, Washington County, Maryland, and Allegheny County, Pennsylvania. A random sample of age-eligible Medicare benefi ciaries and age-eligible household members were recruited. Exclusion criteria were being wheelchair bound in the home, unable to participate in a clinic examination at the fi eld center, undergoing active treatment for cancer, or planning to move in less than 3 years ( 2 ). The 5-year mortality report ( 14 ) included the original cohort of 5,201 men and women, whereas this report includes the original and added minority cohort. Protocols were approved by each participating institutional review board. All participants gave informed consent. Analysis including ApoE ε 4 was restricted to those giving specifi c consent for analysis of genetic data.
Baseline Evaluation
Participants completed standardized interviews and an extensive examination at the fi eld center in 1989 -1990 for the original and in 1992 -1993 for the minority cohort. The baseline data sets for the original and minority cohorts were combined. Although baseline data collection was comparable for many variables, echocardiography and nutritional assessment were not assessed in the minority cohort, thus these variables were not included in this analysis.
Examinations included demographic characteristics, medications used, health history, noninvasive testing, and blood assays along with self-assessed health status, health habits, physical activity, and physical function ( 2 ) . Race was defi ned by self-report as white, black, or other. The few of other race were grouped with the whites for analysis purposes. Medication use in the past 2 weeks was assessed. Only diuretic use was included here based on a signifi cant association in the previous 5-year follow-up. Health history included self-report of physician diagnosis of myocardial infarction, angina, congestive heart failure (CHF), intermittent claudication, stroke, transient ischemic attack, asthma, emphysema and chronic bronchitis (chronic lung disease), hypertension, diabetes, renal disease, arthritis, and cancer ( 2 ). Self-reported diagnoses of cardiovascular disease were validated according to standardized criteria including medications used and/or medical record review ( 15 ) . Standardized examinations performed on all participants included electrocardiogram ( 15 , 16 , 17 ) , spirometry ( 18 ) , ankle -arm index ( 19 ) , and carotid ultrasound ( 20 ) to measure the maximal stenosis and internal and common carotid artery wall thickness. Other assessments included blood pressure, height, and weight. Diabetes was defi ned by self-report and medication use or the presence of fasting glucose level greater than 126 mg/dl ( 21 ) . Hypertension was defi ned as self-report of a diagnosis of hypertension confi rmed by medication use or by a measured blood pressure of 140/90 mmHg or greater. Depressive symptoms were assessed using the Center for Epidemiological Studies-Depression scale questionnaire ( 22 ) . Cognitive function was assessed with the Mini-Mental State Examination ( 23 ) and the Digit Symbol Substitution Test (DSST) ( 24 ) . Performance-based measures of physical function included gait speed in meters per second at usual pace and grip strength in kilograms assessed with an isometric dynamometer ( 2 ) . Phlebotomy was performed under fasting conditions, and the blood was analyzed by the Laboratory for Clinical Biochemistry Research at the University of Vermont for levels of glucose, total cholesterol, and high-density lipoprotein cholesterol, serum albumin, creatinine, and fi brinogen. Low-density lipoprotein cholesterol was calculated ( 25 ) . ApoE ε 4 genotype was assessed and grouped as the presence or absence of at least one ε 4 allele ( 26 , 27 ) . CRP ( 28 ) and were measured by use of enzyme-linked immunosorbent assays.
Ascertainment of Mortality and Cause of Death
Study participants were followed for an average of 13 years (<1 to 16 years), from 1989 -1990 to 2006 (16 years) for the original cohort and from 1992 -1993 to 2006 (13 years) for the minority cohort. Mortality, hospitalizations, and cardiovascular events were ascertained at annual examinations and 6-month telephone interviews. If the participant was unavailable, a proxy was interviewed. Deaths were also identifi ed from obituaries. Data collection included information from medical records, proxy interviews, and death certifi cates. Follow-up for vital status was 100% complete. For all deaths, the cause of death was considered to be the underlying cause rather than the immediate cause of death. Cause of death was assigned by a committee of physicians who were without knowledge of prior examination fi ndings. Cause of death was fi rst determined to be cardiovascular or noncardiovascular. Cardiovascular deaths included atherosclerotic coronary disease, cerebrovascular disease (stroke), other atherosclerotic disease (such as aortic aneurysm), and other vascular disease (such as valvular heart disease or pulmonary embolism). The noncardiovascular deaths were fi rst classifi ed into 19 disease and organ system categories, then collapsed into fi ve categories: dementia, cancer, pulmonary disease, infection, and " other " cause ( 30 ) . Dementia death was classifi ed when there was evidence of advanced disability due to dementia prior to death and no evidence of another cause. Cancer deaths included all cancer types. Pulmonary death included chronic obstructive pulmonary disease, pulmonary embolism, and respiratory failure. Infectious death included pneumonia, sepsis, and other infections. Death secondary to " other " causes included renal failure, liver failure, gastrointestinal (GI) disease (GI hemorrhage, perforated viscus, other GI disorders), trauma, amyotrophic lateral sclerosis, Parkinson ' s disease, epilepsy, metabolic disease, amyloidosis, hip fracture, failure to thrive, myelodysplastic syndrome, and other musculoskeletal diseases.
Analysis
Mortality rates were calculated per 100 person-years. Survival curves for the CHS cohort were compared with an age-, race-, and sex-matched sample from the U.S. population. The CHS survival curves were computed using the Kaplan -Meier estimator with left truncation (entry) at baseline age. The population curves were computed using Hakulinen ' s method ( 31 ) , in which person-time was computed for each participant starting at recruitment and ending at the end of follow-up. In these curves, the probability of death was computed for each day from age -sex -race-specifi c mortality tables derived from the U.S. 1990 Census data by Therneau and Offord ( 32 ) , and the expected numbers of deaths are aggregated across all study participants at risk. Both of the CHS and the U.S. estimated curves are based on assumptions that the risk at a certain age is the same regardless of age at entry into CHS. The census-based estimate was computed from the probability that a person of any given age would die during the following year.
The baseline characteristics described above that were previously examined as potential risk factors for total mortality were fi rst reexamined using Cox proportional hazards models. Each risk factor was examined in either quintiles of events (weight, physical activity, forced vital capacity [FVC] , systolic blood pressure [SBP], fasting glucose, albumin, creatinine, IL-6, and DSST) based on the 5-year models 2 or clinical meaningful groupings (age, smoking, carotid stenosis, ankle -brachial index, self-reported health, CRP, and instrumental activities of daily living [IADL] impairments). Newer models were compared with each other but could not be specifi cally compared with the previous 5-year mortality analysis for several reasons. First, we wanted to include race, which was not included in the previous report. Second, the risk factor assessment was slightly different in the minority cohort, and third, the coding of some variables had been changed. Thus, we could not directly replicate the previous analysis. However, in preliminary analysis, a model based on most variables from the 5-year mortality analysis was compared with (a) a full model with 70 variables, (b) a " best predictive " model, and (c) the original model with IL-6, CRP, and ApoE ε 4 added. The best predictive model was selected from the 70 variables by all-subsets branch-and-bound search using the method of Lawless and Singhal ( 33 ) . These analyses showed that the prediction from the original model was similar to those other models in that the areas under the receiver operating characteristic curves were not signifi cantly different. Thus, for total mortality, we present a model based on the variables from the 5-year analysis plus the newer risk factors of race, IL-6, CRP, and ApoE ε 4 . Because informed consent was more limited for the genetics data, the sample size was decreased from 5,888 to 5,222 for models including ApoE ε 4 but the models with the larger number were not substantively different.
To evaluate the commonality of risk factors across cause of death, separate models for each cause were tested using the same set of variables from the model for total mortality. Deaths from a cause other than the primary cause of interest were censored for each model, that is, we censored survival times at competing causes of death ( 34 ) . We repeated the analyses modeling crude incidence of death, that is, when a participant died of one cause, we set time of death for competing causes to the indefi nite future, representing the fact that death from any other cause is then impossible ( 35 ) . These two analyses gave very similar hazard ratios, so we present the fi rst approach. All analyses were conducted using R version 2.7.1 (R Foundation, Vienna, Austria).
R esults
Participants were aged 65 years and older at baseline with a mean age of 72.8 years; 15.7% were black, 84.3% were white or other ethnic group, and 57.6% were women. Though somewhat healthier than the general population, chronic conditions were common and more common in blacks than in whites. Table 1 provides a detailed description of men and women by race.
We fi rst compared the survival curves from the CHS with the U.S. Census data. Figure 1 shows survival curves for black and white men and women in the CHS and for the U.S. population standardized to the CHS age -sex -race distribution. All the CHS survival curves were signifi cantly different from the U.S. population curves (all p values <.001). Survival starting 5 years after recruitment was less different than the U.S. population but has remained statistically signifi cantly lower. Median survival time was more than 87 years for the women and more than 80 years for the men in the CHS cohort. Men had lower median survival than women and blacks had signifi cantly poorer median survival than whites, although older black women in CHS had better survival at the 75th percentile than older white women.
Factors associated with total mortality at 16 years of follow-up are presented in Table 2 . The risk factors for total mortality were consistent with the previously published fi ndings at 5 years (2). Age was strongly associated with mortality. Smoking, pulmonary function, and body weight were each associated with risk of death. DSST, CHF history, coronary heart disease history, and selfreported health were also predictive of mortality. Male sex and most cardiovascular measures and blood measures were also associated with mortality. ApoE ε 4 allele and Notes: ADA = American Diabetes Association; ADL = activities of daily living; ApoE ε 4 = apolipoprotein E e4; BP = blood pressure; BMI = body mass index; CRP = C-reactive protein; CVD = cardiovascular disease; DSST = Digit Symbol Substitution Test; ECG = electrocardiogram; HDL = high-density lipoprotein; IADL = instrumental activities of daily living; IL-6 = interleukin-6; LDL = low-density lipoprotein; MMSE = Mini-Mental State Examination.
* Geometric mean.
IL-6 levels were both associated with higher total mortality risk. When compared with a model excluding these variables, the relationship of the other variables in the reported model with total mortality was not different (data not shown). Of note, black race was associated with a lower risk of death in these adjusted models. Cause-specifi c mortality was then examined using these same variables. Numbers and rates for each cause are shown in Table 3 . Mean age at death shows that cancer deaths tended to occur at younger ages, whereas dementia death occurred at older ages. To illustrate the risk factors that tended to be related to multiple causes of death, we present a series of fi gures for each of these factors, adjusted for all other risk factors. Older age ( Figure 2A ) was associated with higher risk for all causes of death and was especially strong for dementia and infectious death, where the hazards ratios were approximately 10-fold higher compared with ages 65 -69 years.
Other than age, only a few other factors were consistently associated with multiple causes of death. Higher weight ( Figure 2B ) tended to be inversely associated with death from any cause and signifi cantly so for cardiovascular, dementia, pulmonary, and infectious causes of death. FVC ( Figure 2C ) tended to be associated with all causes of death though only signifi cant for cardiovascular disease, pulmonary, infectious, and other causes of death. Serum creatinine ( Figure 2D ) tended to be associated with all causes of death, but this was only signifi cant for cardiovascular, cancer, infectious, and other cause. A higher DSST score ( Figure 2E ), a measure of cognitive speed, tended to be protective for all causes, except pulmonary death, and was signifi cant for cardiovascular, stroke, dementia, and infectious death. IL-6 level ( Figure 2F ) was associated with all causes except dementia death.
Within each cause of death, risk factors were examined and are presented in Figure 3A -G . Each model included all risk factors, although only signifi cant associations are shown. Multiple risk factors were associated with cardiovascular death, whereas fewer factors were found to be associated with the other causes ( Figure 3A ) . Although numerous noninvasive tests of cardiovascular function were considered, each contributed independently to prediction of cardiovascular disease mortality. Male sex, age, white race, lower physical activity, lower weight, and lower DSST , by gender and race with age at death for the 25th, 50th, and 75th percentile. Gender difference in age at death: log-rank test X 2 = 172, p < .0001. Race difference in age at death: log-rank test stratifi ed by gender: X 2 = 5.3, p = .0217. In women: X 2 = 4.6, p = .03, in men: X 2 = 4.1, p = .04. score were also related to cardiovascular disease death, as were higher glucose, lower albumin, higher creatinine, and higher IL-6 level. Stroke death was associated with older age, poorer self-rated health, lower ankle -arm index, higher SBP, and higher serum creatinine and IL-6 ( Figure 3B ). Cancer death was signifi cantly associated with older age, male sex, smoking, and higher creatinine ( Figure 3C ). Dementia death was associated with older age, white race, higher physical activity, ApoE ε 4 allele, and lower DSST score ( Figure 3D ). Lower FVC as well as smoking and IL-6 were very strongly associated with pulmonary death, whereas higher weight, higher income, and higher physical activity were protective ( Figure 3E ). Infectious cause was associated with older age, male sex, lower weight, higher pulmonary function, higher glucose, poorer IADL performance, higher IL-6 level, and lower DSST score ( Figure 3F ). Other cause was related to older age, male sex, IL-6, glucose, and creatinine ( Figure 3G ).
C onclusions
Specifi c and shared risk factors for specifi c causes of death were identifi ed in this long-term follow-up study of older adults. When examining each cause of death, it was clear that most of the risk factor associations with total mortality were due to the associations of multiple risk factors with cardiovascular death. Some other risk factors were quite specifi c to a given cause of death. For example, lung function was very strongly related to lung disease death, ApoE ε 4 to dementia death, and noninvasive tests for cardiovascular disease were fairly specifi c in their prediction of cardiovascular disease death. Other than age, the factor that was most consistently associated with death across multiple causes was IL-6 level. Older age was especially strongly related to dementia and infectious death; the median age of death for these causes was 87 and 85 years, respectively.
In spite of the extensive baseline characterization of this cohort, there were few factors identifi ed that were common risk factors for all causes of death and none trumped age itself in its consistency for predicting all cause categories. Dysfunction of two organ systems, the lung and kidney, tended to be related to multiple causes of death, though not all estimates were statistically signifi cant. Others have noted that dysfunction of these two organ systems is strongly linked to mortality ( 36 , 37 ) , although the reasons are not well understood. Lower weight tended to be associated with all causes of death, but especially for infectious and pulmonary death. This paradox of higher weight being protective in older adults has been previously noted in many studies of total mortality ( 38 ) and is now shown here to be consistent across many causes of death.
Higher IL-6, a marker of dysregulation of immune function and a chronic infl ammatory state, was consistently related to all causes though it was not statistically signifi cant for dementia death. This may be due to survival bias related to the very old age at death in that group. Higher IL-6 is related to frailty status ( 39 ) , total mortality ( 40 ) , and disability ( 41 ) and thus appears to capture the general decline of aging.
Association of mortality with the digit symbol score suggests that brain function is key to longevity ( 42 , 43 ) . It was striking that ApoE ε 4 allele was so strongly related to dementia death and not the other types. Our data show that its low prevalence in very long-lived people maybe specifi cally due to higher dementia mortality.
Interpreting cause-specifi c mortality is always complicated by the fact that the death of a participant from one cause makes it impossible to observe when they otherwise would have died from other causes. The effects of exposures on the observed time and cause of death may not have a simple relationship to their effects on physiological processes because of the steady removal of susceptible individuals from the cohort ( 44 ) . There is no complete statistical solution to this problem, but we conducted a sensitivity analysis that suggested that the results are not very sensitive to the dependence between causes of death. Our primary analyses yielded similar hazard ratios to a model where we set time of death for competing causes to the indefi nite future ( 35 ) . This suggests that the risk estimates are robust to competing cause.
There are several limitations that should be kept in mind when examining these results. First, we did not attempt to identify all risk factors for death; rather, we reevaluated previously identifi ed baseline risk factors with longer-term follow-up. Although other models might yield additional insights into causal relationships, the overall prediction of death was not improved with more complex models. Future models could also evaluate change in risk over time. Another limitation was the lack of detail on cancer death in these analyses. It is well known that risk factors differ by cancer type, so further analysis of cancer deaths is needed. Finally, there are certainly additional risk factors that would be important for the noncardiovascular causes of death that were not assessed as part of the CHS.
These fi ndings have important implications for aging research. First, the specifi city of some risk factors for the eventual cause of death suggests that death may be ultimately determined by the failure of the most limited organ system. In other words, we were able to identify the " weakest link " leading to death. Although comorbidity is common and other conditions certainly contribute to death, these fi ndings provide support for the approach of assigning a specifi c cause of death in older adults ( 45 ) . The fi ndings of the common risk factor IL-6 support the concept that there is an underlying age-related state of decline that is not disease specifi c ( 11 ) .
The importance of infl ammation, cognitive function, kidney, and lung function across causes suggests that these systems have less reserve, decline more strongly with age over time or with risk factor exposure, or simply that these systems have fewer mechanisms for adaptation or repair of injury than do other systems. It is also possible that these systems were more accurately measured than others in this study. These fi ndings also have important implications for clinical practice. Handheld portable spirometery and kidney function are easily measured and could be incorporated into risk assessment. Body weight is most easily monitored and of importance in predicting death across multiple causes. Table 2 for total mortality. CVD = cardiovascular disease. 
